Inflation Reduction Act proves positive boost for biosimilars

For the pharma industry, the IRA has made headlines due to it allowing price negotiations on top-selling treatments. However, Ben Hargreaves finds that another provision within the Act was designed to encourage biosimilar uptake, and it seems to be working.